Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 15.28 CNY 0.39% Market Closed
Market Cap: 27.9B CNY

Hualan Biological Engineering Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Hualan Biological Engineering Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Hualan Biological Engineering Inc
SZSE:002007
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
5%
Beigene Ltd
HKEX:6160
EPS (Diluted)
-ÂĄ3
CAGR 3-Years
21%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
EPS (Diluted)
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
EPS (Diluted)
ÂĄ0
CAGR 3-Years
23%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-63%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
EPS (Diluted)
-ÂĄ1
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hualan Biological Engineering Inc
Glance View

Market Cap
27.9B CNY
Industry
Biotechnology

Hualan Biological Engineering Inc., nestled in the heart of China, operates at the crossroads of innovation and health, focusing primarily on the production of vaccines and blood products. The company is at the forefront of a critical industry, ensuring the creation of products that play a pivotal role in maintaining public health. With a dedicated pursuit of scientific excellence, Hualan develops vaccines that protect against contagious diseases and specializes in plasma-derived therapeutics that have become a backbone in treating a variety of conditions requiring immune support or clotting factors. This dual focus not only showcases their expertise but also broadens their commercial portfolio, tapping into markets where demand is continually rising. Revenue streams for Hualan Biological are primarily driven by their deep penetration into domestic markets, where there is a growing emphasis on healthcare innovation and quality assurance. The company capitalizes on its research and development capabilities, which have enabled it to secure a strong pipeline of products and stay ahead in a competitive landscape. By leveraging its robust distribution network and quality manufacturing processes, Hualan ensures that its products reach hospitals and health institutions rapidly. This strategic orchestration of science and logistics allows Hualan not only to generate substantial revenues but also to reinforce its reputation as a leader within China's biopharmaceutical sector, ensuring it remains a vital contributor to public health initiatives.

Intrinsic Value
19.39 CNY
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Hualan Biological Engineering Inc's EPS (Diluted)?
EPS (Diluted)
0.5 CNY

Based on the financial report for Sep 30, 2025, Hualan Biological Engineering Inc's EPS (Diluted) amounts to 0.5 CNY.

What is Hualan Biological Engineering Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%

Over the last year, the EPS (Diluted) growth was -29%. The average annual EPS (Diluted) growth rates for Hualan Biological Engineering Inc have been -6% over the past three years , -6% over the past five years , and 5% over the past ten years .

Back to Top